Conditional funding of medical technologies will be replaced by the Subsidy Scheme for Promising Care in the Netherlands

19

Sep 2018

Research must determine whether new methods of medical care can be included in a basic package. Before a new method of care can be reimbursed from the basic health insurance package, evidence is required that it is at least as effective as standard treatment. However, this type of research is often expensive, requires a lot of expertise and lasts for several years. With the budget that is now available for this, developers, hospitals and researchers can set up this research more easily. After the research project has ended, an assessment by the Dutch Healthcare Institute will be made to determine whether the new method can be included in the basic package.

The Healthcare Institute is preparing for the implementation of the new subsidy scheme in the coming months. Currently, there are still plans for conditional reimbursement for evaluation of medical technologies that has started in recent years. The old regulation remains in effect for these ongoing processes.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more

18

Feb 2022

Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.

Read more